Home Subjects Financial Results

Financial Results

Torrent Pharma up 3%; issues commercial paper of Rs 300 cr, board meeting on...

A meeting of the board of directors will be held on May 30, 2018, to consider and approve the audited financial results for the year ended March 31, 2018. New Delhi, June 01, 2018: Shares of Torrent Pharmaceuticals added 3.8 percent intraday Monday...

Morepen Labs Reports Growth-filled Fourth Quarter to Close FY 2017-18 with a 25 Per...

New Delhi, May 18, 2018: Highlights 12M FY 2017-18 (Consolidated) Net profit rises by 25 per cent at Rs. 29.59 Crore. Net Sales Revenue up by 1.9 per cent at Rs. 598 crore. Domestic sales up by 21.3 per cent at Rs....

Aditya Birla Capital reports results for the year ended 31st March, 2018

Key Highlights ·         Consolidated revenue, on a like-to-like1 basis, increased 21%, over the prior year, to              ` 13,428 Crore from ` 11,071 Crore. ·         Consolidated earnings before tax (EBT), on a like-to-like1 basis, increased 35% over the prior year, to `...

LiveHealth raises USD1 1M in seed funding

Mumbai, March 06, 2018: LiveHealth, a leader in digitizing diagnostic lab workflows has raised a seed round of USD1. 1M from Nexus Venture Partners. LiveHealth seamlessly digitizes records from diagnostic laboratories through its SaaS platform and makes them available on the...

Apollo Hospitals announces Q3FY18 results

New Delhi, February 15, 2018: Q3FY18 Standalone Revenues grew 13% to Rs. 18,961 million compared to Rs. 16,806 million in Q3FY17, aided by Healthcare services growth of 13% YoY, fully driven by volume growth and SAP growth of 13%. HC services...

Granules India’s Revenue from operation increases by 14% to INR 411 Cr.

Mumbai, February 09, 2018: Granules India Ltd., a growing pharmaceutical manufacturing company, announced today financial results for its third quarter ended 31st December, 2017.             Quarterly Financial Highlights of Q3FY18 Consolidated              Margins (%) Revenue:                    INR 411 Cr. EBITDA:                       INR 75 Cr.       ...

HealthCare Global Enterprises Ltd. reports Q3-FY18 results

Revenue for Q3 FY18 of INR 2,063 Million, a growth of 17% (y-o-y) and for 9M FY18 of INR 6,084 Million, a growth of 17.5% (y-o-y) EBITDA for Q3 FY18 at INR 319 Million, a growth of 15.3% (yo-y) and...

Natco Pharma Q3 net benefit up 12% at Rs 217.4 cr

New Delhi, February 08, 2018: The organization had posted a benefit after assessment of Rs 194.9 crore for the comparing time of the past monetary, Natco Pharma said in a BSE documenting. Medication firm Natco Pharma today detailed a 11.54...

Glaxosmithkline Pharma’s Q3FY18 net profit rises 69.39%

The company’s consolidated revenue stood at Rs703.91cr, down 0.35% yoy and 15.83% qoq. New Delhi, February 06, 2018:  Glaxosmithkline Pharma Ltd Q3FY18 Consolidated Results Q3FY18: (Rs. in crore) Q3FY18 YoY (%) Revenue 703.91 EBITDA 141.81 172.1 EBITDA Margin (%) 20.2 1,277 Net Profit (adjusted) 89.69 69.4 GlaxoSmithKline Pharmaceuticals reported flat growth in its revenue to Rs703.9cr...

Dr.Reddy’s Laboratories posts net profit of Rs 334 cr for third quarter

Hyderabad, January 28, 2018: Pharma Major Dr.Reddy's Laboratories has posted a profit (after tax) of Rs.334 crore for the third quarter ended December 2017. The profit accounted for 8.8 per cent of the Company's Revenues of Rs 3,806 crore during the...